Black Hawk Acquisition Corporation Units (BKHAU)
Company News
Vesicor Therapeutics, Inc. and Black Hawk Acquisition Corporation Enter into a Business Combination Agreement to Create a Biotechnology Company Advancing p53-based Cancer Therapeutics Delivered Via Microvesicles
Vesicor Therapeutics, a biotechnology company focused on p53-based cancer therapeutics, has entered into a business combination agreement with Black Hawk Acquisition Corporation to create a public company advancing its drug candidate.
CORRECTION: Black Hawk Acquisition Corporation Welcomes Mr. Jonathan Ginsberg to Board
DANVILLE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Black Hawk Acquisitions Corporation (NASDAQ: BKHAU), please note that the second paragraph reference to Mr. Ginsberg meeting "the independent director standards of The Nasdaq Stock Market" has been removed. The corrected release follows: